862
M. Sedlák, P. Drabina, V. Lánský, J. Svoboda
Vol 45
CH2CH3), 7.54 (bs, 1H, CONH2), 7.62 (m, 2H, Ar), 7.73 (bs,
1H, CONH2), 7.93 (m, 1H, Ar), 8.13 (m, 1H, Ar), 8.73 (bs, 1H,
CONH); 13C NMR: δ 12.8, 27.4, 32.6, 65.7, 122.2, 127.1, 127.8,
130.3, 132.0, 138.6, 140.8, 141.3, 162.6, 179.5; EI-MS: m/z 310,
266, 195 (100 %), 167, 132, 123. Anal. Calcd. for
C14H15ClN2O2S (310.8): C, 54.10; H, 4.86; Cl, 11.41; N, 9.01; S,
10.32. Found: C, 54.28; H, 5.06; Cl, 11.65; N, 8.83; S, 10.12.
N-(2-Carbamoyl-3-methylbut-2-yl)-3-chlorobenzo[b]thio-
phene-2-carboxamide (1b). Yield 2.75 g (85 %); mp 186-
152-153 °C; 1H NMR: δ 0.78 (d, J = 6.8 Hz, 3H, iPrCH3), δ 0.95
(d, J = 6.8 Hz, 3H, iPrCH3), 1.24 (s, 3H, CH3), 1.91 (sp,
J = 6.8 Hz, 1H, iPrCH), 7.57 (m, 2H, Ar), 7.87 (m, 1H, Ar),
8.08 (m, 1H, Ar), 11.29 (bs, 1H, CONH); 13C NMR: δ 21.0,
66.0, 117.8, 122.1, 125.2, 129.8, 133.7, 141.8, 145.7, 150.5,
153.2, 169.3; EI-MS: m/z 306, 263 (100 %),194, 159, 132, 114.
Anal. Calcd. for C15H15ClN2OS (306.1): C, 58.72; H, 4.93; Cl,
11.56; N, 9.13; S, 10.45. Found: C, 58.86; H, 4.79; Cl, 11.41;
N, 9.12; S, 10.34.
2-(3-Chlorobenzo[b]thiophene-2-yl)-4-isobutyl-4-methyl-4,
5-dihydro-1H-imidazol-5-one (2c). Yield 1.52 g (97 %); mp
150-151 °C; 1H NMR: 0.86 (d, J = 6.5 Hz 3H, iBuCH3), 1.03 (d,
J = 6.5 Hz 3H, iBuCH3), 1.27 (s, 3H, CH3), 1.52 (sp, J = 6.5 Hz,
1H, iBuCH), 1.62 (m, 1H, iBuCH2), 1.76 (m, 1H, iBuCH2),
7.60 (m, 2H, Ar), 7.91 (m, 1H, Ar), 8.12 (m, 1H, Ar), 11.34 (bs,
1H, CONH); 13C NMR: δ 23.3, 24.1, 24.4, 24.6, 46.5, 70.0,
122.4, 123.4, 126.1, 128.0, 136.1, 137.2, 148.5, 153.7, 185.6;
EI-MS: m/z 320, 305, 277, 264, 249, 207, 194 (100 %), 159,
114, 84, 57. Anal. Calcd. for C16H17ClN2OS (320.1): C, 59.90;
H, 5.34; Cl, 11.05; N, 8.73; S, 9.99. Found: C, 59.93; H, 5.40;
Cl, 10.88; N, 9.12; S, 9.89.
2-(3-Chlorobenzo[b]thiophene-2-yl)-4-tert-butyl-4-methyl-4,
5-dihydro-1H-imidazol-5-one (2d). Yield 1.18 g (74 %); mp
197-200 °C; 1H NMR: δ 1.04 (s, 9H, C(CH3)3), 1.31 (s, 3H,
CH3), 7.66 (m, 2H, Ar), 7.97 (m, 1H, Ar), 8.18 (m, 1H, Ar),
11.31 (bs, 1H, CONH); 13C NMR: δ 18.4, 24.6, 36.2, 74.5, 95.0,
105.2, 122.5, 123.4, 125.7, 126.1, 127.8, 136.1, 152.6, 186.6,
191.8, 197.3; EI-MS: m/z 320, 264 (100 %), 194, 159, 114, 57.
Anal. Calcd. for C16H17ClN2OS (320.1): C, 59.90; H, 5.34; Cl,
11.05; N, 8.73; S, 9.99. Found: C, 60.09; H, 5.44; Cl, 10.78; N,
8.67; S, 9.98.
1
187 °C; H NMR: δ 0.94 (d, J = 6.8 Hz, 3H, iPrCH3), δ 1.04 (d,
J = 6.8 Hz, 3H, iPrCH3), 1.57 (s, 3H, CH3), 2.27 (sp, J = 6.8 Hz,
1H, iPrCH), 7.23 (bs, 1H, CONH2), 7.40 (bs, 1H, CONH2),
7.63 (m, 2H, Ar), 7.94 (m, 1H, Ar), 8.12 (m, 1H, Ar), 8.18 (bs,
1H, CONH); 13C NMR: δ 17.6, 17.7, 34.8, 37.5. 64.1, 118.5,
123.1, 123.7, 126,4; 128.0, 134.3, 136.7, 137.1, 159.6, 174.9; EI-
MS: m/z 324, 280, 195 (100 %), 167, 132, 123. Anal. Calcd. for
C15H17ClN2O2S (324.8): C, 55.46; H, 5.28; Cl, 10.91; N, 8.62; S,
10.32. Found: C, 55.56; H, 5.13; Cl, 10.96; N, 8.59; S, 10.07.
N-(2-Carbamoyl-4-methylpent-2-yl)-3-chlorobenzo[b]thio-
phene-2-carboxamide (1c). Yield 2.21 g (65 %); mp 147-
149 °C; 1H NMR: 0.82 (d, J = 7.0 Hz 3H, iBuCH3), 0.84 (d,
J = 7.0 Hz 3H, iBuCH3), 1.56 (sp, 3J = 7.0 Hz, 1H, iBuCH),
1.62 (s, 3H, CH3), 1.79 (m, 1H, iBuCH2), 2.43 (m, 1H, iBuCH2),
7.55 (bs, 1H, CONH2), 7.58 (m, 2H, Ar), 7.74 (bs, 1H, CONH2),
7.89 (m, 1H, Ar), 8.09 (m, 1H, Ar), 8.88 (bs, 1H, CONH); 13C
NMR: δ 23.0, 23.3, 24.4, 24.7, 43.0, 60.4, 117.5, 122.7, 123.3,
125.9, 127.6, 134.2, 136.4, 136.8, 158.0, 175.7; EI-MS: m/z
338, 294, 264, 207, 195 (100 %), 167, 132, 123. Anal. Calcd. for
C16H19ClN2O2S (338.9): C, 56.71; H, 5.65; Cl, 10.46; N, 8.27; S,
9.46. Found: C, 56.98; H, 5.76; Cl, 10.66; N, 8.39; S, 9.52.
N-(2-Carbamoyl-3,3-dimethylbut-2-yl)-3-chlorobenzo[b]-
thiophene-2-carboxamide (1d). Yield 2.08 g (61 %); mp 209-
Synthesis of 2-(3-chlorobenzo[b]thiophene-2-yl)-4-iso-
propyl-1,4-dimethyl-4,5-dihydro-1H-imidazol-5-one (3a). The
reaction was performed on a vacuum-argon line. 2-(3-Chloro-
benzo[b]thiophen-2-yl)-4-isopropyl-4-methyl-4,5-dihydro-1H-
imidazol-5-one (2b) (1.53 g; 5 mmol) was suspended in
potassium tert-butyl alcoholate (20 mL; 0.50 mol·L–1). After
dissolution, the solvent tert-butyl alcohol was distilled off. The
evaporation residue was dissolved in dry N,N-dimethyl-
formamide (10 mL). After cooling to 0 °C, methyl iodide
(0.63 ml; 10 mmol) was added and the temperature of the
reaction mixture spontaneously increased up to 25 °C. After 24
hours, N,N-dimethylformamide was distilled off and the
evaporation residue was mixed with distilled water and extracted
with dimethyl ether (3 × 20 mL). The product was obtained by
evaporating the combined dried diethyl ether extracts. Yield
1
210 °C; H NMR: δ 1.13 (s, 9H, C(CH3)3), 1.68 (s, 3H, CH3),
7.25 (s, 1H, CONH2), 7.36 (bs, 1H, CONH2), 7.63 (m, 2H, Ar),
7.90 (bs, 1H, CONH), 7.94 (m, 1H, Ar), 8.14 (m, 1H, Ar),
8.36 (bs, 1H, CONH); 13C NMR: δ 17.4, 26.2, 36.8, 66.2, 79.4,
117.8, 122.9, 123.6, 126.1, 127.8, 134.9, 136.6, 137.0, 159.3,
173.0; EI-MS: m/z 264 (100 %), 207, 194, 159, 114, 57. Anal.
Calcd. for C16H19ClN2O2S (338.9): C, 56.71; H, 5.65; Cl, 10.46;
N, 8.27; S, 9.46. Found: C, 56.52; H, 5.62; Cl, 10.38; N, 8.30;
S, 9.43.
General method of preparation of substituted 4,5-dihydro-
1H-imidazol-5-ones (2a-d). The respective substituted
aminoamide 1a–d (5 mmol) was added to sodium methoxide
solution (25 mL; 1 mol·L–1). After 72-hour stirring at room
temperature, the pH value of reaction mixture was adjusted at
pH ~ 5-6 (HCl aq., 5 mol·L–1). The suspension formed was
evaporated, and the dry evaporation residue was washed with
1
1.45 g (91 %); mp 57-59 °C; H NMR: δ 0.86 (d, J = 6.5 Hz 3H,
iPrCH3), 1.03 (d, J = 6.5 Hz 3H, iPrCH3), 1.34 (s, 3H, CH3),
1.96 (sp, J = 6.6 Hz, 1H, iPrCH), 3.03 (s, 3H, NCH3), 7.68 (m,
2H, Ar), 7.98 (m, 1H, Ar), 8.24 (m, 1H, Ar); 13C NMR: δ 16.6;
16.8, 20.9, 27.5, 34.2, 74.1, 121.4, 122.4, 123.6, 124.5, 126.2,
127.5, 135.3, 137.5, 154.7, 185.0; EI-MS: m/z 320, 277
(100 %), 208, 193, 158, 114. Anal. Calcd. for C16H17ClN2OS
(320.1): C, 59.90; H, 5.34; Cl, 11.05; N, 8.73; S, 9.99. Found: C,
60.13; H, 5.43; Cl, 11.00; N, 8.74; S, 9.93.
Synthesis of 1-benzyl-2-(3-chlorobenzo[b]thiophene-2-yl)-4-
isopropyl-4-methyl-4,5-dihydro-1H-imidazol-5-one (3b). The
reaction was performed on a vacuum-argon line. Benzyl
bromide (1.2 ml; 10 mmol) was added to a mixture of 2-(3-
chlorbenzo[b]thiophen-2-yl)-4-isopropyl-4-methyl-4,5-dihydro-
1H-imidazol-5-one (2b) (1.85 g; 6 mmol) and cesium carbonate
(1.38 g; 10 mmol) in dry N,N-dimethylformamide (15 mL).
distilled water (2
× 10 mL). The remaining solid was
recrystallized from ethanol or an ethanol/water mixture.
2-(3-Chlorobenzo[b]thiophene-2-yl)-4-ethyl-4-methyl-4,5-
dihydro-1H-imidazol-5-one (2a). Yield 1 g (69 %); mp 144-
1
147 °C; H NMR: δ 0.78 (t, J = 7.3 Hz, 3H, CH2CH3), 1.35 (s,
3H, CH3), 1.78 (m, 2H, CH2CH3), 7.65 (m, 2H, Ar), 7.97 (m,
1H, Ar), 8.18 (m, 1H, Ar), 11.32 (bs, 1H, CONH); 13C NMR: δ
7.9, 22.6, 30.3, 61.3, 117.8, 122.5, 123.3, 126.1, 127.6, 128.0,
136.0, 136.8, 158.2. 175.1; EI-MS: m/z 292, 277, 263, 229, 214,
194 (100 %), 159, 132, 114. Anal. Calcd. for C14H13ClN2OS
(292.0): C, 57.43; H, 4.48; Cl, 12.11; N, 9.57; S, 10.95. Found:
C, 57.66; H, 4.59; Cl, 12.23; N, 9.62; S, 10.74.
2-(3-Chlorobenzo[b]thiophene-2-yl)-4-isopropyl-4-methyl-4,
5-dihydro-1H-imidazol-5-one (2b). Yield 1.18 g (77 %); mp